Drugs / Exforge
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | EXFORGE | — | 2007-06-20 | fda.gov ↗ |
| Approved | EU (EMA) | Exforge | — | 2007-01-16 | europa.eu ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01536353 Comparator | Jan → Apr 2012 | hypertensive disorder | Ahn-Gook Pharmaceuticals Co.,Ltd | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Exforge | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01536353 ↗ |